[HTML][HTML] Splicing mutations in human genetic disorders: examples, detection, and confirmation
A Anna, G Monika - Journal of applied genetics, 2018 - Springer
Precise pre-mRNA splicing, essential for appropriate protein translation, depends on the
presence of consensus “cis” sequences that define exon-intron boundaries and regulatory …
presence of consensus “cis” sequences that define exon-intron boundaries and regulatory …
Pick one, but be quick: 5′ splice sites and the problems of too many choices
X Roca, AR Krainer, IC Eperon - Genes & development, 2013 - genesdev.cshlp.org
Splice site selection is fundamental to pre-mRNA splicing and the expansion of genomic
coding potential. 5′ Splice sites (5′ ss) are the critical elements at the 5′ end of introns …
coding potential. 5′ Splice sites (5′ ss) are the critical elements at the 5′ end of introns …
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants
C Houdayer, V Caux‐Moncoutier, S Krieger… - Human …, 2012 - Wiley Online Library
Assessing the impact of variants of unknown significance (VUS) on splicing is a key issue in
molecular diagnosis. This impact can be predicted by in silico tools, but proper evaluation …
molecular diagnosis. This impact can be predicted by in silico tools, but proper evaluation …
Benchmarking deep learning splice prediction tools using functional splice assays
Hereditary disorders are frequently caused by genetic variants that affect pre‐messenger
RNA splicing. Though genetic variants in the canonical splice motifs are almost always …
RNA splicing. Though genetic variants in the canonical splice motifs are almost always …
Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications
A Aartsma-Rus, GJB Van Ommen - Rna, 2007 - rnajournal.cshlp.org
Antisense-mediated modulation of splicing is one of the few fields where antisense
oligonucleotides (AONs) have been able to live up to their expectations. In this approach …
oligonucleotides (AONs) have been able to live up to their expectations. In this approach …
NF1 Molecular Characterization and Neurofibromatosis Type I Genotype–Phenotype Correlation: The French Experience
ABSTRACT Neurofibromatosis type 1 (NF 1) affects about one in 3,500 people in all ethnic
groups. Most NF 1 patients have private loss‐of‐function mutations scattered along the NF 1 …
groups. Most NF 1 patients have private loss‐of‐function mutations scattered along the NF 1 …
SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing
Modeling splicing is essential for tackling the challenge of variant interpretation as each
nucleotide variation can be pathogenic by affecting pre‐mRNA splicing via …
nucleotide variation can be pathogenic by affecting pre‐mRNA splicing via …
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort
Variant interpretation is the key issue in molecular diagnosis. Spliceogenic variants
exemplify this issue as each nucleotide variant can be deleterious via disruption or creation …
exemplify this issue as each nucleotide variant can be deleterious via disruption or creation …
[HTML][HTML] A highly sensitive genetic protocol to detect NF1 mutations
MC Valero, Y Martín, E Hernández-Imaz… - The Journal of Molecular …, 2011 - Elsevier
Neurofibromatosis type 1 (NF1) is a hereditary disorder caused by mutations in the NF1
gene. Detecting mutation in NF1 is hindered by the gene's large size, the lack of mutation …
gene. Detecting mutation in NF1 is hindered by the gene's large size, the lack of mutation …
How does the Schwann cell lineage form tumors in NF1?
SL Carroll, N Ratner - Glia, 2008 - Wiley Online Library
Neurofibromas are benign tumors of peripheral nerve that occur sporadically or in patients
with the autosomal dominant tumor predisposition syndrome neurofibromatosis type 1 …
with the autosomal dominant tumor predisposition syndrome neurofibromatosis type 1 …